United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$357.87 USD
+2.28 (0.64%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $357.80 -0.07 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | 6.21 |
EPS Last Quarter | 5.85 |
Last EPS Surprise | -7.58% |
ABR | 1.79 |
Earnings ESP
|
3.66% |
---|---|
Current Year | 24.84 |
Next Year | 27.84 |
EPS (TTM) | 21.76 |
P/E (F1) | 14.32 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 719.92M | 712.94M | 2.82B | 3.03B |
# of Estimates | 6 | 6 | 7 | 7 |
High Estimate | 767.70M | 763.60M | 2.89B | 3.23B |
Low Estimate | 677.83M | 658.99M | 2.73B | 2.72B |
Year ago Sales | 609.40M | 614.70M | 2.33B | 2.82B |
Year over Year Growth Est. | 18.14% | 15.98% | 21.31% | 7.30% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.21 | 6.59 | 24.84 | 27.84 |
# of Estimates | 8 | 6 | 9 | 9 |
Most Recent Consensus | 5.88 | 5.40 | 23.30 | 24.86 |
High Estimate | 7.41 | 7.83 | 27.16 | 35.85 |
Low Estimate | 5.41 | 5.11 | 22.83 | 20.89 |
Year ago EPS | 5.38 | 4.36 | 19.81 | 24.84 |
Year over Year Growth Est. | 15.43% | 51.15% | 25.39% | 12.10% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 1 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 0 | 0 |
Up Last 60 Days | 2 | 5 | 3 | 5 |
Down Last 7 Days | 1 | 0 | 1 | 1 |
Down Last 30 Days | 1 | 0 | 1 | 2 |
Down Last 60 Days | 4 | 1 | 6 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 6.21 | 6.59 | 24.84 | 27.84 |
7 Days Ago | 6.33 | 6.51 | 24.86 | 27.92 |
30 Days Ago | 6.33 | 6.51 | 24.86 | 27.94 |
60 Days Ago | 6.69 | 6.07 | 25.52 | 28.02 |
90 Days Ago | 6.49 | 5.25 | 24.48 | 26.81 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 6.44 | 6.53 | 24.97 | 26.70 |
Zacks Consensus Estimate | 6.21 | 6.59 | 24.84 | 27.84 |
Earnings ESP | 3.66% | -0.89% | 0.53% | -4.13% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 5.85 | 6.17 | 4.36 | 5.38 | NA |
Estimate | 6.33 | 5.63 | 3.92 | 4.89 | NA |
Difference | -0.48 | 0.54 | 0.44 | 0.49 | 0.25 |
Surprise | -7.58% | 9.59% | 11.22% | 10.02% | 5.81% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more